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The Role of Terminal Functionality in the Membrane and 
Antibacterial Activity of Peptaibol-Mimetic Aib Foldamers 
Catherine Adam,[a] Anna D. Peters,[b],[c] M. Giovanna Lizio,[b],[c] George F. S. Whitehead,[b] Vincent 
Diemer,[b],[c] James A. Cooper,[d] Scott L. Cockroft,[d] Jonathan Clayden*[a] and Simon J. Webb*[b],[c] 
 
Abstract: Peptaibols are peptide antibiotics that typically feature an 
N-terminal acetyl cap, a C-terminal aminoalcohol, and a high 
proportion of α-aminoisobutyric acid (Aib) residues. To establish how 
each feature might affect the membrane-activity of peptaibols, 
biomimetic Aib foldamers with different lengths and terminal groups 
were synthesised. Vesicle assays showed that long foldamers 
(eleven Aib residues) with hydrophobic termini had the highest 
ionophoric activity. C-terminal acids or primary amides inhibited 
activity, while replacement of an N-terminal acetyl with an azide 
group made little difference. Crystallography showed that 
N3Aib11CH2OTIPS folded into a 310 helix 2.91 nm long, which is close 
to the bilayer hydrophobic width. Planar bilayer conductance assays 
showed discrete ion channels only for N-acetylated foldamers. 
However long foldamers with hydrophobic termini had the highest 
antibacterial activity, indicating that ionophoric activity in vesicles 
was a better indicator of antibacterial activity than the observation of 
discrete ion channels. 
Introduction 
Peptaibols are a class of antimicrobial peptide secreted by 
Trichoderma fungi.[1] Common structural features of peptaibols 
include acylated N-termini (acetyl in long peptaibols or C8 to 
C15 acyl chains in lipopeptaibols[2]), a high proportion of the 
non-coded amino acid α-aminoisobutyric acid (Aib) and usually 
(although not exclusively[3,4]) a C-terminal aminoalcohol residue. 
The prevalence of quaternary residues, such as Aib, promotes 
folding into 310- or α-helical secondary structures,
[5] and the 
resulting lipophilic helices can be highly membrane active. The 
most commonly studied peptaibol, 19-residue alamethicin, forms 
voltage-dependant ion channels in lipid membranes[6] and this 
channel formation is implicated in its bactericidal activity.[7] 
Alamethicin has an N-terminal acetyl group and a C-terminal 
phenylalaninol residue, and is predominantly α-helical with a 
length of ca. 2.8 nm.[8] The formation of membrane-spanning 
pores is thought to depend upon the aggregation of 3 to 12 
alamethicin helices in the membrane; the tethering of six or 
seven alamethicin peptides to a central hub leads to remarkably 
stable ion channels.[9] Although alamethicin shows good activity 
against fungi and Gram-positive bacteria, its toxicity to 
mammalian cells impairs medical applications.[7,10] 
The creation of synthetic channel-forming compounds[11,12] 
can lead to a better understanding of how membrane-active 
antibiotics like peptaibols form channels and pores. It may also 
provide new classes of antibiotics that could help overcome the 
growing problem of antibiotic resistance.[13] Despite the potential 
applications of synthetic channel-forming compounds, few 
studies have elucidated structure-activity relationships that link 
activity in non-biological membranes with activity against cells,[14] 
although Gokel and co-workers correlated the channel-forming 
activity of synthetic hydraphile channels in phospholipid bilayers 
with activity against bacterial and mammalian cells.[15] 
Given that an N-terminal acetyl group and a C-terminal 
alcohol are such common structural features of the antimicrobial 
peptaibols, it seems reasonable to propose that these 
modifications are important for the antibiotic function of these 
compounds. Both of these features have the potential to 
hydrogen bond to adjacent residues and thereby stabilise folded 
secondary structures, such as α- and 310-helices; in peptaibols 
both inter- and intramolecular hydrogen bonds to the terminal 
hydroxyl have been observed.[8b,16] It has also been suggested 
that a hydroxyl group stabilises ion channels by hydrogen 
bonding to the glycerol and phosphate in phospholipid 
headgroups.[17] Analogous peptaibol derivatives with esters at 
the C-terminus are reported to still be membrane active,[18] and 
in some cases to be as effective as the alcohols.[19] Acetylation 
at the N-terminus is widespread in peptides and proteins and is 
known to play many roles, including regulating protein stability, 
membrane targeting and gene silencing.[20] 
Developing synthetic molecular devices able to 
communicate chemicals or information across membranes is an 
area of keen interest.[11,12,21,22] We have shown that Aib-rich 
foldamers can act as synthetic ion channels[23] and membrane-
spanning signal transducers,[21b,c] in the latter case using their 
dynamic conformational properties to transmit photochemical 
and chemical information deep into phospholipid bilayers. To 
extend transduction studies into a cellular environment, it is 
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necessary to understand which structural features in these Aib 
foldamers may promote ionophoric behaviour. In addition, the 
modular nature of synthetic compounds, in which chain length 
and chain termini can be modulated freely, makes Aib foldamers 
valuable model systems for understanding peptaibol behaviour. 
Having recently shown the importance of Aib foldamer length in 
determining ionophoric activity,[22,23] we now sought to 
investigate how the N-terminal acetyl and C-terminal hydroxyl 
groups found in channel-forming peptaibols affect the ionophoric 
activity of Aib foldamers. In an era of increased antibiotic 
resistance, such studies may allow the design of optimised 
peptaibol antibiotics. 
Results and Discussion 
Foldamer synthesis  
 
 
Figure 1. (a) General structure of α-aminoisobutyric acid (Aib) foldamers in a 
310-helical conformation. (b) Aib foldamers synthesised as part of this study; 
“Aibn” refers to the number of Aib-like residues in the chain. (c) Aib foldamers 
synthesised according to published procedures
[23]
 and analysed herein. (d) 
Iterative synthesis of foldamers 1-5, 6-15. i) EDC.HCl, CH2Cl2; ii) 
H2NCMe2CH2OTIPS; iii) EtOH, HCl; iv) H2, Pd/C, EtOH/MeOH v) Ac2O, 
CH2Cl2; vi) EDC.HCl, CH2Cl2, N3Aib3OH. TIPS = Si(iPr)3. 
We have observed membrane activity for Aib foldamers 
containing as few as 5 residues,[22] but studies on the 
N3AibnC(O)CH2CH2SiMe3 compound family (n = 4 to 13) showed 
a strong increase in activity when n ≥ 9 (Figure 1c).[23] Planar 
bilayer conductance (PBC) studies showed clear channel-like 
behaviour for n = 11 and 13, but not for n = 7 and 8.[23] 
Nonetheless, this earlier systematic study only examined the 
behaviour of foldamers bearing hydrophobic termini. 
To allow comparisons to be made with the peptaibols, we 
synthesised new foldamers 2 - 4, 6 - 10, 12 - 15 (Figure 1b), with 
lengths on either side of the apparent nine-residue cut-off for 
good membrane activity but also containing functional groups 
commonly found in the naturally occurring peptaibols (acetyl at 
N-terminus, hydroxyl at C-terminus). As control compounds, we 
also assessed foldamers 1, 5, 11, 16 – 18, which had non-polar 
functional groups at both termini that cannot participate in a 310-
helix hydrogen-bonding network. 
 
Figure 2. X-ray crystal structures of (a) N3Aib11CH2OTIPS 11, (b, c) 
N3Aib8CH2OH 7. Selected hydrogen bonds are shown in dashed green. 
Foldamer 7 is shown in b) plan and c) axial views to show the C-terminal 
hydrogen bond and 310 helix axis respectively. Methyl and methylene 
hydrogens removed for clarity. Grey = C, Blue = N, Red = O, White = H, 
Orange = Si. 
Choosing only three lengths of peptides to assess, namely 
“Aib5”, “Aib8” and “Aib11”, simplified the synthetic routes to these 
compounds. The synthetic routes started from the tetramer 
peptide, N3Aib4OH 19,
[24] which was then coupled to the 
protected 1,2-aminoalcohol H2NCMe2CH2OTIPS 
(“AibCH2OTIPS”) to give compound 1. This compound was 
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either deprotected at the C-terminus to release the free alcohol 3, 
reduced then acetylated at the N-terminus to give 2, or reduced 
then coupled with N3Aib3OH trimer to give 5. This chain 
extension gave access to the “Aib8” and “Aib11” series of 
compounds after analogous chemical transformations. 
Compounds 1, 5 and 11 have non-polar groups at both termini, 
and additional non-polar reference compounds 16, 17 and 18 
were synthesised according to literature methods.[23] 
The solid-state structure of a foldamer with non-polar 
termini, N3Aib11CH2OTIPS 11 (Figure 2a), shows that the Aib 
core folds into a 310-helical secondary structure with the silylated 
tail adopting an extended conformation. The foldamer has an 
end-to-end distance of 2.91 nm, which is commensurate with the 
hydrophobic width of a phospholipid bilayer (e.g. 
EYPC:cholesterol bilayers, ca. 2.8 nm).[23,25] The solid-state 
structure of a shorter foldamer with a hydroxyl C-terminus, 
N3Aib8CH2OH 7 (Figure 2b), also shows a 310-helical core (view 
down axis, Figure 2c) with an end-to-end distance of 1.87 nm. 
The C-terminal hydroxyl forms a strong hydrogen bond with the 
preceding Aib residue (H to O distance 1.868 Å, Figure 2b,c) 
instead of hydrogen bonding to the carbonyl of the i + 3 Aib 
residue, which would continue the 310 helix (H to O distances in 
the 310-helix backbone typically 2.1 to 2.2 Å). This is in contrast 
to N-terminal acylation of Aib foldamers, which adds a hydrogen 
bond (from the amide carbonyl) that supports the 310-helical 
structure, as shown in the structure of AcAib4OtBu.
[26] 
 
8-Hydroxypyrene-1,3,6-trisulfonate (HPTS) assays  
 
The HPTS assay is widely used to assess the ionophoric ability 
of compounds.[27] The HPTS dye is a ratiometrically sensitive 
probe that can report on the discharge of a pH gradient 
established between the exterior and interior of phospholipid 
vesicles. The discharge of the gradient can occur via H+/M+ 
antiport or H+/X− symport. The measured rate of change of the 
pH reflects a number of molecular level events, including the 
rate of membrane insertion as well as the conductance induced 
by the compounds.[27]  
HPTS assays were carried out on compounds 1-15 using 
procedures developed previously.[23] Aliquots of foldamers in 
methanol were equilibrated for 180 s with suspensions of large 
unilamellar vesicles (composed of 4:1 egg yolk 
phosphatidylcholine:cholesterol mol/mol, 800 nm diameter) in 
MOPS buffer (20 mM MOPS, 100 mM NaCl, pH 7.4). Then a 
NaOH base pulse was used to change the external pH to 8.4 
and the subsequent change in HPTS fluorescence was 
measured. The addition of Triton X-100 27 minutes later lysed 
the vesicles and provided the maximum change in HPTS 
fluorescence for data normalisation. 
As found previously,[23] the ability of Aib foldamers to 
discharge a pH gradient showed a clear length dependence 
(Figure 3). The fractional discharge of the ion gradient after 1000 
s (normalised against Triton X-100 addition) can give a measure 
of the activity of each compound. By this measure, each 
incremental addition of an Aib3 unit to homologous foldamers 
gives an order of magnitude increase in activity, i.e. similar 
HPTS activity to 10-fold higher concentrations of the shorter 
homologues (see the ESI).  
 
Figure 3. Normalised HPTS fluorescence responses for foldamers. a) 9 mol % 
foldamer to lipid, 100 µM unless stated otherwise. AcAib5CH2OTIPS (66 µM 
(saturated), yellow, ●), N3Aib5CH2OTIPS (purple, ●), N3Aib5CH2OH (blue, ●) 
AcAib5CH2OH (red, ●); MeOH (black, ●). b) 0.9 mol % foldamer to lipid, 10 µM. 
AcAib8CH2OTIPS (yellow, ●) N3Aib8CH2OTIPS (purple, ●), N3Aib8CONH2 
(green, ●), AcAib8CH2OH (red, ●) N3Aib8CH2OH (blue, ●) N3Aib8CO2H (orange, 
●); MeOH (black, ●). c) 0.09 mol % foldamer to lipid, 1 µM unless stated 
otherwise. Alamethicin (gray dots), N3Aib11CH2OTIPS (purple, ●), 
N3Aib11CH2OH (blue, ●), AcAib11CH2OTIPS (yellow, ●), AcAib11CH2OH (red, 
●), N3Aib11CO2H (7 µM, orange, ●), THF (black, ●). 
Upon comparing the effect of different termini within a 
family of foldamers of given length, a pattern emerges. Those 
compounds with the hydrophobic TIPS group at the C-terminus 
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show consistently high activity, which appears to be altered little 
by an acetyl group at the N-terminus. Polar modifications at the 
C-terminus seem to be detrimental to activity, with the alcohols 
showing lower activity and the acids (predominantly present as 
the carboxylates) showing very low activity even at a seven-fold 
greater concentration (Figure 3c). This loss of activity for 
foldamer 9 mirrors the loss of activity reported for trichogin GA 
IV analogues that have a C-terminal carboxylate, an effect 
ascribed to electrostatic repulsion with the lipid phosphate 
groups.[18a] The one foldamer with a C-terminal primary amide 
that was tested (N3Aib8C(O)NH2) also showed a decrease in 
ionophoric activity compared to a TIPS. Only in the Aib11 series 
of compounds did a C-terminal alcohol show high activity, albeit 
still lower that the TIPS protected analogue. These longer 
foldamers with non-polar termini had activity in these HPTS 
assays that was around 70% of that shown by alamethicin 
(Figure 3c). 
These observations suggest that the length of the foldamer 
and the ability to partition into the hydrophobic part of the bilayer 
are the most import factors in determining ionophoric activity.  
 
Planar bilayer conductance assays 
 
Planar bilayer conductance (PBC) data can provide information 
on the mechanism by which ionophoric compounds conduct ions 
across membranes; the appearance of discrete conductance 
events can indicate the formation of channels and provide 
information on their behaviour. 
Alamethicin has been well studied by PBC, producing 
discrete conductance events that are thought to be due to 
‘barrel-stave’ multimeric channels comprising 3-12 helical 
monomers. The number of peptide units in a channel is dynamic, 
producing multiple conductance levels that correspond to 
channels of different molecularity.[6b,c] Alamethicin also shows 
non-ohmic behaviour, with high positive potentials (+100 mV, 10 
nM peptide) producing bursts of discrete conducting states 
ranging from 0.52 to 5.0 nS that arise from relatively large 
conductance “barrel-stave” channels.[28] 
Aib foldamers with hydrophobic termini have been shown 
to have PBC behaviour similar to that of alamethicin. 
Incrementally longer foldamers (N3AibnC(O)OCH2CH2TMS, n = 7, 
8, 11, 13) were studied by PBC in EYPC/cholesterol 4:1 
bilayers.[23] At ≤5 μM the shortest two foldamers produced 
irregular and “spike” conductances (using terminology proposed 
by Chiu and Fyles[29]), indicating transient membrane disruption, 
and at ≥10 µM they caused the membranes to break. The longer 
compounds did not weaken the membrane in the same way, 
with “multi-level” and “flicker” behaviour observed. The “open” 
states typically lasted <0.2 s, and were of varied conductance 
between 100 and 5000 pS. Quantised steps in the conductance 
levels were not observed, suggesting that multiple openings of 
the same type of pore did not occur. 
 Foldamers with different lengths that also showed good 
ionophoric activity in the HPTS assays were selected for PBC 
assays; AcAib8CH2OTIPS 6, AcAib8CH2OH 8, N3Aib8C(O)NH2 
10, N3Aib11CH2OTIPS 11, AcAib11CH2OTIPS 12, N3Aib11CH2OH 
13, AcAib11CH2OH 14. At 16 μM none of these compounds 
caused the membranes to break, but they showed clear 
differences in conductance behaviour.  
 Discrete conductance events were only observed for 
compounds with N-acetyl termini, whereas foldamers 8, 11 and 
13 showed few or no conductance events within 7 h of addition 
to the membrane. N3Aib8C(O)NH2 10 was mostly inactive or with 
low level conductance. However three of the four acetylated 
compounds gave regular “square-top” activity, which lasted up to 
500 ms for 6 and 12 and several minutes for 14, along with 
flickering and erratic conductances (Figure 4). 
 
Figure 4. a) Examples of planar bilayer conductance for 6, 12 and 14, all 16 
μM. Applied voltages indicated for each trace, zero current position by 
horizontal line, arrow indicates size and direction of current. (a) 6 
(AcAib8CH2OTIPS), max current passed +9 pA. (b) 6, max. current passed 
+34 pA. (c) 12 (AcAib11CH2OTIPS), steps of +25, +76 and +101 pA from 
baseline; maximum may be due to four open pores. (d) 12, current passed for 
smaller steps +17 pA. (e) 14 (AcAib11CH2OH), max. current passed between 
closed and open states shown, step size -34 pA, max. current passed –48 pA. 
(f) 14, max. current passed –23 pA. 
In contrast to inactive AcAib8CH2OH 8, AcAib8CH2OTIPS 6 
showed some conductance behaviour although this was not as 
consistent as the longer peptides. “Multilevel” activity (Figure 4a) 
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was observed as well as “square-top” activity arising from stable 
pores with on/off activity at similar current levels (up to 34 pA at 
+100 mV, Figure 4b). AcAib11CH2OTIPS 12 gave “square-top” 
conductance events within 20 minutes (Figure 4c), with spiky 
traces also frequently observed (Figure 4d). The “square-top” 
events suggested channels with the same level of conductance 
were formed, which opened and closed much more frequently 
(open channel lifetimes were typically <100 ms) than those 
observed for AcAib11CH2OH 14. Foldamer 14 gave conductance 
events more slowly than 12, but around 2 h after addition of 14 
to the cis well, a stable pore opened (Figure 4e) following a 
period of spiky conductance and ill-defined pore formation 
(Figure 4f). For both 12 and 14, it may be that the transient 
conductance events are due to incomplete channel formation. 
Notably, the same conductance was measured in multiple, 
repeat experiments, indicating this compound reproducibly forms 
a pore of the same dimensions, rather than poorly-defined 
membrane weakening. This reproducible quantised membrane 
activity indicates ion channel formation with the same 
molecularity for each pore. The lifetime and magnitude of the 
“open” conductance state of these channels (ca. 300 pS over 
500 ms to several seconds) were distinct from typically reported 
square-topped traces (10–30 pS conductance over 1–10 s 
durations),[29] but similar to those seen for 
N3AibnC(O)OCH2CH2TMS (n = 11 or 13). Comparing the 
behaviour of 12 and 14 suggests that a C-terminal alcohol may 
stabilise the open state of the pore, resulting in the observed 
quantised channel opening/gating behaviour. 
 These PBC studies indicate that the presence of an N-
terminal acetyl group correlates with the observation of 
conductance events arising from discrete channels. An N-
terminal acetyl group is known to stabilise folding, increase the 
end-to-end dipole, and strongly promote self-association of Aib 
foldamers in hydrophobic environments,[26] all factors that should 
promote ion channel formation. In contrast a C-terminal hydroxyl 
group did not produce a marked increase in conductance events 
in the PBC assays, even though the duration of pore opening for 
AcAib11CH2OH 14 was significantly longer than for the other 
foldamers. A C-terminal TIPS group did improve PBC activity in 
one case (e.g. 6 vs. 8), although an N-terminal acetyl group was 
also present. It may be that the lack of a distinct effect occurs 
because the terminal hydroxyl of the reduced Aib forms an i→
i+1 hydrogen bond (as found in 7) instead of an i →i+3 hydrogen 
bond that continues, and potentially stabilises, the membrane-
spanning 310-helix. It is interesting to note that in natural 
peptaibols the reduced C-terminal residue is never an Aib.[30] 
 Clear channel forming behaviour in the PBC studies did 
not always correlate with good ionophoric activity in HPTS 
assays. Some foldamers that showed long-lived, stable pores in 
single channel studies (e.g. 12 and 14) had lower HPTS activity 
than analogous N-terminal azides that showed no activity in the 
PBC assays (e.g. 11 and 13 showed no activity within 7 h of 
addition). It is possible that the latter may form channels with 
lifetimes too brief to be observed as discrete events by PBC (i.e. 
μs rather than ms durations). This would result in a small, but 
constant ion current leakage across the bilayer that is difficult to 
distinguish from drift in the electrode potentials, or background 
leakage of the bilayer over the duration of the experiments. 
Alternatively, there may be a different mechanism of action 
under an applied voltage that favours channel formation. For 
example, an external field may induce transmembrane 
alignment of compounds, such as peptides, which have strong 
end-to-end dipoles[31] that increase with helical length.[32] 
Furthermore, the voltage-induced flow of ions through a channel 
may help to maintain open channels. Indeed, PBC 
measurements are performed under out-of-equilibrium 
conditions (constant transmembrane potential gradient), 
whereas the HPTS assay is approaching equilibrium over time 
(dissipating a transmembrane ion gradient). 
 
Antibacterial activity assays 
 
It has been proposed that the antibiotic activity exhibited by 
alamethicin against yeast and Gram-positive bacterial strains 
arises from the formation of high-conductance channels in 
cellular membranes.[7] To assess the antibiotic activity of these 
foldamers, simple and qualitative measure can be obtained 
using an agar diffusion assay. After plating of the bacterial strain 
onto the dish, a methanol solution of the compound of interest is 
evaporated at a point on an agar plate, allowing the compound 
to diffuse into the agar gel.[33] After incubation for a set time 
period, a zone of growth inhibition (Figure 5a) occurs where the 
compound has prevented bacterial growth. 
Foldamers N3Aib8CH2OH 7, AcAib8CH2OTIPS 6, 
AcAib11CH2OH 14 and N3Aib11CH2OTIPS 11 were selected for 
antibiotic assays against Bacillus megaterium strain DSM319 as 
they had shown either good ionophoric activity in the HPTS 
assay and/or discrete conductance events in the PBC assays. 
Alamethicin, which has good activity against B. megaterium,[34] 
was used as a reference compound, along with 16, 17 and 18, 
which had been previously assessed for ionophoric activity 
(HPTS assays for 16, 17, 18; PBC assay for 18).[23]  
After addition of 0.4 nmol compound (1 μL of 400 μM stock, 
mass from 0.3 μg for 7 to 0.46 μg for 11) then plating of B. 
megaterium strain DSM319 onto the Petri dish (150 mm 
diameter), the resulting diameter of the inhibition zone (IZ) was 
measured after incubation at 30 °C for 16-18 h. Clear 
differences were observed between compounds with different C-
termini. The TIPS/TMS terminated compounds all showed 
moderate (6) or good activity (11, 17 and 18), yet the hydroxyl 
terminated compounds (7 and 14) showed no activity above the 
methanol control. The longer compounds 11, 17, 18 with 
hydrophobic termini showed activity that was comparable to that 
of alamethicin (0.4 nmol, 0.8 μg). Doubling the amounts on the 
agar to 0.8 nmol increased the size of the inhibition zone for 14 
(IZ = 0.41 ± 0.06 cm, 11, 17, 18 all have IZ > 1 cm), but not for 
shorter foldamer 7 (IZ = 0.08 ± 0.04 cm); both are inactive 
relative to methanol (see ESI). This antibacterial activity was not 
caused by the Aib residue itself, as the tetrameric foldamer 
N3Aib4C(O)OCH2CH2TMS and hexameric foldamer 16 showed 
very low activity even at 1 nmol (0.48 µg and 0.63 µg). Much like 
alamethicin,[7] none of the foldamers examined showed activity 
against Gram-negative E. coli. 
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Figure 5. (a) Photograph of agar plate with MeOH and foldamers (each 0.4 
and 0.8 nmol) added: AcAib8CH2OTIPS 6, N3Aib8CH2OH 7, N3Aib11CH2OTIPS 
11, AcAib11CH2OH 14, N3Aib12C(O)OCH2CH2SiMe3 17, N3Aib13TMS 18, and 
alamethicin. Scale bar 1 cm. (b) Inhibition zone diameters against B. 
megaterium strain DSM319 (cm, mean of 12 measurements) for foldamers 6, 
7, 11, 14, 17, 18 and N3Aib6TMS 16. Each foldamer is 0.4 nmol except Aib 
hexamer 16 (1.0 nmol). Standard errors of the mean are shown. 
These data from the agar diffusion assays are only 
qualitative, but indicate that the structure-activity relationship for 
antibacterial activity corresponds best with that found for the 
HPTS assay, with compound length (i.e. 17, 18 > 16) and C-
terminal lipophilicity (i.e. 6 > 7) playing key roles. Unfortunately 
the effect of an N-terminal acetyl group on antibacterial activity 
could not be conclusively identified due to the limited range of 
compounds studied. However, the existence of lipopeptaibols,[2] 
which combine a short peptide component with a N-terminal acyl 
chain (C8 to C15), suggests that N-terminal lipophilicity can also 
be beneficial. In line with previous results,[23] increasing the 
foldamer length beyond ten Aib residues, and hence forming a 
310 helix longer than that needed to span the hydrophobic core, 
did not seem to produce a significant increase in antibacterial 
activity. Increasing the length of the foldamer core beyond Aib10 
does however lead to sharply lower solubility in organic solvents. 
Conclusions 
An N-terminal acetyl group can allow Aib foldamers to form long-
lived and well-defined channels in planar bilayers, and did not in 
general adversely affect ionophoric performance in vesicles or 
antibacterial behaviour. Although it does not produce a 
significant improvement in activity in either vesicle or cell assays 
compared to an N-terminal azide, we suggest that a role of N-
terminal acyl groups in peptaibols is to mask the basic amine 
and make this terminus less hydrophilic. Indeed it has been 
suggested that peptaibols have N-terminal acyl groups and C-
terminal 1,2-aminoalcohols simply to remove the respective 
positive and negative charges from their backbones.[35] We also 
propose that an N-terminal acetyl group plays a role in 
stabilising the helical secondary structure required to span the 
membrane by extending the hydrogen-bonding network. 
Furthermore the lack of PBC activity for otherwise very active N-
terminal azide foldamers suggests that solely using patch-clamp 
methods to screen for membrane activity may result in promising 
lead compounds for antibiotics being overlooked. 
 In contrast, a C-terminal hydroxyl group mildly inhibited 
activity in the vesicle assays and significantly diminished 
antibacterial activity compared to C-terminal esters. Given 
reports that C-terminal esters of peptaibolin are as membrane 
active as the corresponding alcohols,[16b] and that the membrane 
and antibacterial activities of C-terminal ester analogues of 
trichogin GA IV are either comparable[19] or slightly weaker[18a] 
than the parent compound, it may be that a C-terminal hydroxyl 
functions as a hydrolytically stable modification with lower 
polarity than a carboxylate. It is interesting to note that recent 
studies have indicated that, when compared to the C-terminal 
methyl ester analogue, the C-terminal alcohol in trichogin GA IV 
leads to significantly higher toxicity against human cell lines but 
not bacteria.[18a] However our studies do not pinpoint the role 
played by the C-terminal hydroxyl in the antibiotic activity of 
peptaibols, as the natural compounds do not have a reduced Aib 
at the C-terminus;[30] perhaps a gem-dimethyl stabilises a i→i+1 
hydrogen bond (as observed in 7) over other arrangements that 
facilitate channel formation. 
Synthetic foldamers that mimic the behaviour of the 
peptaibols could lead to new antibiotics bearing bioactive motifs 
that are not biologically accessible. Our studies indicate there is 
substantial scope for modifying the termini of an Aib foldamer 
core, which may even provide synthetic peptaibols with 
improved selectivity for bacterial over mammalian cells. 
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Experimental Section 
The synthetic procedures for the preparation of new foldamers 1 to 15 
are reported in the Supporting Information, along with corresponding 1H 
NMR and 13C NMR spectra. Foldamers 16 to 18 were prepared 
according to literature procedures.[23] X-ray crystallography details are 
reported in the Supporting Information. Structural data for 7 and 11 have 
been deposited with the Cambridge Crystallographic Data Centre. CCDC 
1582012 and 1582013 contain the supplementary crystallographic data 
for 7 and 11 respectively. These data can be obtained free of charge 
from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. Procedures for HPTS, PBC and 
antibacterial assays are also reported in the Supporting Information. 
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groups were synthesised. The longest 
foldamers (eleven residues) with 
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ionophoric activity in vesicles and best 
antibacterial activity, but only N-
acetylated foldamers produced long-
lived discrete ion channels. 
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